Late Episodes of Acute Rejection in Renal Transplantation:Experience with 83 Cadavaric Renal Allograft Recipients
季曙明,周广臣,陈劲松,殷立平,沙国柱,尹广,陈惠萍,黎磊石
DOI: https://doi.org/10.3969/j.issn.1006-298x.2002.04.004
2002-01-01
Abstract:Objective:To investigate the clinical and pathological features of acute rejection(AR) beyond one year after renal transplantation,we retrospectively analyzed the clinical and pathologic data in 83 cadavaric renal allograft recipients in one transplantation center. Methodology:Between Jan 1994 and Dec 1999 in Jinling Hospital,83 patients in 494 cadaveric renal allograft recipients developed late episodes of acute renal allograft rejection beyond one year after the transplantation.All the episodes occurred when the allografts were functioning,and may clinically presented with acute deterioration of renal filtration,enlargement and pain of the allograft,uncontrolled hypertension,oliguria and weight gain.A percutaneous allograft biopsy was timely performed in each patient with each episodes of acute rejection.The pathological diagnosis were made by a panel of renal pathologists and nephrologist,according to the Banff criteria for acute renal allograft rejection. Results:Within a mean period of follow up for 43 6(13～64 months),54 pratients developed a first episode of AR after one years of transplantation,21 developed the second episode of AR,and 8 developed the third episode of AR.Among them,6 episodes of AR occurred because of improper reduction of the dosage of immunosuppressants.Clinically 56 4% recipients with late AR presented with uncontrolled hypertension(61 7%),oliguria(44 7%),or weight gain(38 8%),while 43 4% were asymptomatic.And pathologically,31 recipients with clinical AR showed the features of acute cellular rejection,and 42 showed the features of chronic rejection (CR) besides those of AR.87 9% of the recipients with late AR responded to a high dose steroid treatment,with 100% for those with the first AR,81 0% for those with the second AR,and partial or no response for those with the third AR.After the salvage anti rejection treatment,17(54 8%) recipients with acute cellular rejection were reversed completely,and 14(45 2%) were partially reversed.For those 42 patients with pathologic AR features and CR features,6 were completely reversed,34 partially reversed and 2 not reversed.During the follow up of these patients with late AR,it was found that better graft survival was significantly associated with the response to the salvage therapy. Conclusion:Monitoring of AR in later stages is essential for cadaveric renal allograft recipients.The diagnosis of late AR is made with the combination and the clinical features and the pathologic data revealed by the timely allograft biopsy.Responsiveness to antirejection therapy is assoiated with the times of AR and the long term prognosis.